V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210034843 | 210027098 | 1.85 | 88 | Palliative (P) | 2018-06-26 | 2018-08-28 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | N | 210021581 | FCR |
| 210034844 | 210027099 | 1.62 | null | Curative (C) | 2016-01-19 | 2016-02-20 | BENDAMUSTINE + RITUXIMAB | N | N | 210021599 | BENDAMUSTINE + RITUXIMAB |
| 210034845 | 210010255 | 1.8 | 86.5 | Curative (C) | 2015-03-23 | 2015-05-08 | FCR | 2 | N | 210021606 | FCR |
| 210034846 | 210020608 | 1.79 | 74 | Disease modification (D) | 2014-06-06 | 2014-06-06 | FCR Oral - Cycle 2 onwards | N | null | 210021626 | FCR |
| 210034847 | 210010275 | 1.55 | 27.9 | Curative (C) | 2013-06-01 | 2014-04-04 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | N | 210021729 | FCR |
| 210034848 | 210010296 | 1.63 | 41.8 | Palliative (P) | 2017-11-21 | 2018-04-01 | Vincristine (weekly) | N | N | 210021799 | VINCRISTINE |
| 210034849 | 210010302 | 1.16 | 107.7 | Curative (C) | 2016-03-26 | 2016-03-26 | BENDAMUSTINE + RITUXIMAB | N | N | 210021830 | BENDAMUSTINE + RITUXIMAB |
| 210034850 | 210010321 | null | null | Curative (C) | 2016-04-12 | 2016-04-12 | Bendamustine+Rituximab(Sub Courses) | N | null | 210021882 | BENDAMUSTINE + RITUXIMAB |
| 210034851 | 210010332 | 1.29 | 62 | Disease modification (D) | null | 2018-04-27 | VINCRISTINE | N | null | 210021949 | VINCRISTINE |
| 210034852 | 210010378 | 1.8 | 61.5 | Curative (C) | 2016-05-28 | 2016-07-18 | BENDAMUSTINE + RITUXIMAB | N | N | 210022156 | BENDAMUSTINE + RITUXIMAB |
| 210034853 | 210020719 | 1.69 | 86.7 | Curative (C) | 2019-04-29 | 2019-05-28 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 210022299 | FCR |
| 210034854 | 210010404 | null | 41 | null | 2015-05-08 | 2015-05-10 | FCR Oral - Cycle 2 onwards | null | null | 210022448 | FCR |
| 210034855 | 210010418 | null | 57.3 | Not known (9) | null | 2018-09-11 | FCR Oral - Cycle 1 | N | N | 210022620 | FCR |
| 210034856 | 210027154 | 1.58 | null | Curative (C) | 2017-12-22 | 2017-12-29 | CHLORAMBUCIL + RITUXIMAB | Y | null | 210023044 | CHLORAMBUCIL + RITUXIMAB |
| 210034857 | 210010463 | 1.77 | 91 | Curative (C) | null | 2016-08-21 | IMATINIB | 1 | N | 210023222 | IMATINIB |
| 210034858 | 210010468 | 1.65 | 100.9 | Curative (C) | 2016-02-10 | 2016-03-06 | IMATINIB | N | N | 210023251 | IMATINIB |
| 210034859 | 210010493 | 1.74 | 90 | Curative (C) | 2017-05-09 | 2018-01-01 | ALL UKALL60+ TRIAL | 02 | null | 210023423 | UKALL60+ |
| 210034860 | 210010539 | 0 | 87.7 | Curative (C) | 2016-03-07 | 2016-08-08 | ALL UKALL2003 TRIAL | N | N | 210023954 | UKALL 2003 |
| 210034861 | 210010578 | 1.75 | null | Curative (C) | 2019-05-12 | 2019-07-06 | METHOTREXATE | N | N | 210024423 | METHOTREXATE |
| 210034862 | 210010592 | null | 88 | Curative (C) | 2018-10-31 | 2018-12-11 | CHLORAMBUCIL + OBINUTUZUMAB | N | null | 210024563 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210034863 | 210020873 | 1.69 | 43.6 | Curative (C) | 2015-06-05 | 2016-04-20 | IMATINIB | N | N | 210024579 | IMATINIB |
| 210034865 | 210010628 | 1.49 | null | Curative (C) | 2017-05-17 | 2017-05-30 | IMATINIB | Y | N | 210024977 | IMATINIB |
| 210034866 | 210010629 | 1.72 | 18.3 | Curative (C) | 2018-03-23 | 2018-05-11 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210025003 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210034868 | 210010680 | 0 | 52 | Curative (C) | null | 2015-04-15 | CHLORAMBUCIL + OBINUTUZUMAB | Y | N | 210025559 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210034869 | 210010685 | 1.37 | null | Curative (C) | 2017-08-26 | 2017-10-23 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210025630 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210034870 | 210010697 | 1.7 | 59 | Curative (C) | 2016-05-16 | 2016-07-27 | ALL UKALL2003 TRIAL | Y | N | 210025775 | UKALL 2003 |
| 210034871 | 210010759 | 0 | 85.1 | Curative (C) | 2017-07-19 | 2017-08-16 | METHOTREXATE | N | N | 210026643 | METHOTREXATE |
| 210034872 | 210010777 | 1.45 | 72.2 | Curative (C) | 2018-01-31 | 2018-01-31 | ALL UKALL2003 TRIAL | N | N | 210026869 | UKALL 2003 |
| 210034873 | 210010790 | null | null | Disease modification (D) | 2014-06-08 | 2014-07-22 | Triple / Double Intrathecal Therapy | Y | N | 210026957 | TRIPLE INTRATHECAL |
| 210034874 | 210010797 | 1.88 | 73.5 | null | 2017-09-04 | 2017-10-08 | ALL UKALL2003 TRIAL | N | N | 210027027 | UKALL 2003 |
| 210034875 | 210010803 | 1.59 | 67.5 | Disease modification (D) | 2016-03-07 | 2016-05-14 | CHLORAMBUCIL + OBINUTUZUMAB | Y | N | 210027036 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210034876 | 210027286 | 1.64 | 59.7 | Curative (C) | 2014-07-24 | 2014-07-24 | IMATINIB | Y | N | 210027055 | IMATINIB |
| 210034877 | 210010811 | 1.6 | 70 | Curative (C) | 2015-04-04 | 2015-06-10 | IDELALISIB + RITUXIMAB | 2 | N | 210027083 | IDELALISIB + RITUXIMAB |
| 210034878 | 210010813 | 1.61 | 45.1 | Curative (C) | 2017-07-04 | 2017-09-22 | IMATINIB | 1 | N | 210027099 | IMATINIB |
| 210034879 | 210027288 | 1.64 | 60 | null | 2015-03-23 | 2015-07-08 | METHOTREXATE | N | N | 210027114 | METHOTREXATE |
| 210034880 | 210010818 | 0 | 103.6 | Disease modification (D) | 2015-11-01 | 2015-11-08 | Triple / Double Intrathecal Therapy | N | Y | 210027124 | TRIPLE INTRATHECAL |
| 210034881 | 210010852 | 0 | 66.6 | Disease modification (D) | 2015-02-17 | 2015-02-17 | CHLORAMBUCIL + RITUXIMAB | 01 | N | 210027335 | CHLORAMBUCIL + RITUXIMAB |
| 210034882 | 210010866 | 1.34 | 77.7 | Curative (C) | 2019-08-18 | 2019-08-18 | Chlorambucil + Pred + Rituximab | N | N | 210027506 | CHLORAMBUCIL + RITUXIMAB |
| 210034883 | 210010874 | 0 | 88.1 | Curative (C) | 2016-08-10 | 2016-12-19 | Triple / Double Intrathecal Therapy | N | N | 210027529 | TRIPLE INTRATHECAL |
| 210034884 | 210010890 | 1.59 | 83.3 | Disease modification (D) | 2018-01-03 | 2018-01-04 | IDELALISIB + RITUXIMAB | Y | N | 210027613 | IDELALISIB + RITUXIMAB |
| 210034885 | 210021087 | 0 | 78.6 | Disease modification (D) | 2014-02-02 | 2014-03-05 | METHOTREXATE | Y | N | 210027725 | METHOTREXATE |
| 210034886 | 210010905 | 1.73 | 90.2 | Palliative (P) | 2015-08-19 | 2015-08-19 | METHOTREXATE | null | null | 210027736 | METHOTREXATE |
| 210034887 | 210021090 | 1.78 | 99 | Disease modification (D) | 2017-12-23 | 2017-12-26 | METHOTREXATE | N | N | 210027745 | METHOTREXATE |
| 210034888 | 210010912 | 1.77 | 106 | Curative (C) | 2014-01-04 | 2014-03-23 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210027768 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210034889 | 210010920 | 1.86 | 110.7 | Curative (C) | 2017-12-28 | 2017-12-29 | Chlorambucil + Pred + Rituximab | N | N | 210027812 | CHLORAMBUCIL + RITUXIMAB |
| 210034890 | 210010923 | 0 | 52.4 | Curative (C) | 2014-08-29 | 2015-04-24 | ALL UKALL60+ TRIAL | N | N | 210027813 | UKALL60+ |
| 210034891 | 210010927 | 1.59 | 73.1 | Palliative (P) | 2017-02-05 | 2017-06-04 | IMATINIB | Y | N | 210027835 | IMATINIB |
| 210034892 | 210010932 | null | 84.8 | null | 2014-10-17 | 2014-11-19 | IDELALISIB + RITUXIMAB | N | N | 210027853 | IDELALISIB + RITUXIMAB |
| 210034894 | 210010965 | 1.69 | null | Disease modification (D) | 2016-01-17 | 2016-04-10 | Imatinib 400mg | N | N | 210027956 | IMATINIB |
| 210034895 | 210010980 | null | 80 | Curative (C) | 2017-04-29 | 2017-06-12 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210028008 | CHLORAMBUCIL + OBINUTUZUMAB |